Neonatology – DHR Health Institute for Research & Development

Trial Category: Neonatology

D5290C00004 – A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)

View Details →

A MULTI-CENTER PROSPECTIVE ANALYSIS OF NEWBORN DIRECT/CONJUGATED BILIRUBIN SCREENING FOR BILIARY ATRESIA

View Details →

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)

View Details →

AL31A-Growth and Tolerance of Young Infants Fed Milk-Based Infant Formula with Oligosaccharides.

View Details →

AL35- Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula with Added Human Milk Oligosaccharide 2’-Fucosyllactose

View Details →